Literature DB >> 14522859

Bovine spongiform encephalopathy (BSE) and its epidemiology.

Peter G Smith1, Ray Bradley.   

Abstract

Since the recognition of BSE in 1986, over 180,000 cattle in the UK have developed the disease and 1-3 million are likely to have been infected with the BSE agent, most of which were slaughtered for human consumption before developing signs of the disease. The origin of the first case of BSE is unknown, but the epidemic was caused by the recycling of processed waste parts of cattle, some of which were infected with the BSE agent, to other cattle in feed. Control measures have resulted in the consistent decline of the epidemic in the UK since 1992. Cattle and feed exported from the UK have seeded smaller epidemics in other European countries, where control measures were applied later. If the control measures now in place to protect public and animal health are well enforced, the epidemic in cattle should be largely under control and any remaining risk to humans through the consumption of beef should be very small.

Entities:  

Mesh:

Year:  2003        PMID: 14522859     DOI: 10.1093/bmb/66.1.185

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  23 in total

Review 1.  The prion strain phenomenon: molecular basis and unprecedented features.

Authors:  Rodrigo Morales; Karim Abid; Claudio Soto
Journal:  Biochim Biophys Acta       Date:  2006-12-15

2.  Facing up to Complexity: Implications for Our Social Experiments.

Authors:  Ronnie Hawkins
Journal:  Sci Eng Ethics       Date:  2015-06-11       Impact factor: 3.525

3.  Diphenylpyrazole-derived compounds increase survival time of mice after prion infection.

Authors:  Fabienne Leidel; Martin Eiden; Markus Geissen; Hans A Kretzschmar; Armin Giese; Thomas Hirschberger; Paul Tavan; Hermann M Schätzl; Martin H Groschup
Journal:  Antimicrob Agents Chemother       Date:  2011-07-11       Impact factor: 5.191

4.  Transcytosis of murine-adapted bovine spongiform encephalopathy agents in an in vitro bovine M cell model.

Authors:  Kohtaro Miyazawa; Takashi Kanaya; Ikuro Takakura; Sachi Tanaka; Tetsuya Hondo; Hitoshi Watanabe; Michael T Rose; Haruki Kitazawa; Takahiro Yamaguchi; Shigeru Katamine; Noriyuki Nishida; Hisashi Aso
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

5.  A Heparin Purification Process Removes Spiked Transmissible Spongiform Encephalopathy Agent.

Authors:  Cyrus Bett; Ksenija Grgac; Dianna Long; Michael Karfunkle; David A Keire; David M Asher; Luisa Gregori
Journal:  AAPS J       Date:  2017-01-23       Impact factor: 4.009

6.  Lipopolysaccharide induced conversion of recombinant prion protein.

Authors:  Fozia Saleem; Trent C Bjorndahl; Carol L Ladner; Rolando Perez-Pineiro; Burim N Ametaj; David S Wishart
Journal:  Prion       Date:  2014-05-12       Impact factor: 3.931

7.  A case cluster of variant Creutzfeldt-Jakob disease linked to the Kingdom of Saudi Arabia.

Authors:  Michael B Coulthart; Michael D Geschwind; Shireen Qureshi; Nicolas Phielipp; Alex Demarsh; Joseph Y Abrams; Ermias Belay; Pierluigi Gambetti; Gerard H Jansen; Anthony E Lang; Lawrence B Schonberger
Journal:  Brain       Date:  2016-10       Impact factor: 13.501

Review 8.  The importance of ongoing international surveillance for Creutzfeldt-Jakob disease.

Authors:  Neil Watson; Jean-Philippe Brandel; Alison Green; Peter Hermann; Anna Ladogana; Terri Lindsay; Janet Mackenzie; Maurizio Pocchiari; Colin Smith; Inga Zerr; Suvankar Pal
Journal:  Nat Rev Neurol       Date:  2021-05-10       Impact factor: 42.937

9.  A study on the analytical sensitivity of 6 BSE tests used by the Canadian BSE reference laboratory.

Authors:  John G Gray; Sandor Dudas; Stefanie Czub
Journal:  PLoS One       Date:  2011-03-11       Impact factor: 3.240

10.  Exploring the zoonotic potential of animal prion diseases: in vivo and in vitro approaches.

Authors:  Marcelo A Barria; James W Ironside; Mark W Head
Journal:  Prion       Date:  2014 Jan-Feb       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.